SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-009601
Filing Date
2022-04-11
Accepted
2022-04-11 17:03:14
Documents
13
Period of Report
2022-04-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39117
2 ex3-1.htm EX-3.1 6699
  Complete submission text file 0001493152-22-009601.txt   222757

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sonn-20220411.xsd EX-101.SCH 3036
4 XBRL LABEL FILE sonn-20220411_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE sonn-20220411_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3731
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 22820267
SIC: 2834 Pharmaceutical Preparations